Trial · NCT04449029
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | GSK3228836 for 24 Weeks (WK) (on NA Therapy) | 68 | |
| Overall Study | STARTED | GSK3228836 for 12+12 WK (on NA Therapy) | 68 | |
| Overall Study | STARTED | GSK3228836 for 12 WK + Placebo for 12 WK (on NA Therapy) | 68 | |
| Overall Study | STARTED | Placebo for 12 WK + GSK3228836 for 12 WK (on NA Therapy) | 23 | |
| Overall Study | STARTED | GSK3228836 for 24 WK (Not on NA Therapy) | 70 | |
| Overall Study | STARTED | GSK3228836 for 12+12 WK (Not on NA Therapy) | 68 | |
| Overall Study | STARTED | GSK3228836 for 12 WK + Placebo for 12 WK (Not on NA Therapy) | 68 | |
| Overall Study | STARTED | Placebo for 12 WK + GSK3228836 for 12 WK (Not on NA Therapy) | 24 | |
| Overall Study | COMPLETED | GSK3228836 for 24 Weeks (WK) (on NA Therapy) | 65 | |
| Overall Study | COMPLETED | GSK3228836 for 12+12 WK (on NA Therapy) | 65 | |
| Overall Study | COMPLETED | GSK3228836 for 12 WK + Placebo for 12 WK (on NA Therapy) | 66 | |
| Overall Study | COMPLETED | Placebo for 12 WK + GSK3228836 for 12 WK (on NA Therapy) | 22 | |
| Overall Study | COMPLETED | GSK3228836 for 24 WK (Not on NA Therapy) | 64 | |
| Overall Study | COMPLETED | GSK3228836 for 12+12 WK (Not on NA Therapy) | 66 | |
| Overall Study | COMPLETED | GSK3228836 for 12 WK + Placebo for 12 WK (Not on NA Therapy) | 63 | |
| Overall Study | COMPLETED | Placebo for 12 WK + GSK3228836 for 12 WK (Not on NA Therapy) | 24 | |
| Overall Study | NOT COMPLETED | GSK3228836 for 24 Weeks (WK) (on NA Therapy) | 3 | |
| Overall Study | NOT COMPLETED | GSK3228836 for 12+12 WK (on NA Therapy) | 3 | |
| Overall Study | NOT COMPLETED | GSK3228836 for 12 WK + Placebo for 12 WK (on NA Therapy) | 2 | |
| Overall Study | NOT COMPLETED | Placebo for 12 WK + GSK3228836 for 12 WK (on NA Therapy) | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04449029/flow